What we're reading, November 6, 2015: Americans want more aggressive measures to keep healthcare costs in check; the uninsured rate fell to 9% in the first half of 2015; and the federal government warns against restricting access to pricey hepatitis C drugs.
Americans Want More Aggressive Measures to Keep Healthcare Costs in Check
Nearly three-fourths of Americans want price controls placed on drug manufacturers, a sharp increase from 64% a year earlier, the HealthDay/Harris Poll found. In addition, a majority of Americans favor importing cheaper drugs from other countries and allowing Medicare to negotiate prices—two things proposed by both Hillary Clinton and Senator Bernie Sanders as part of their plans to keep rising drug costs in check.
Rate of Uninsured Continues Steady Decline
The uninsured rate was down to just 9% in the first half of 2015, the CDC’s National Center for Health Statistics reported on Thursday. The number of uninsured has dropped 7.5 million from the same time a year earlier, The Wall Street Journal reported. Since the Affordable Care Act was passed in 2010, the uninsured rate has continue a steep and steady decline from 16%.
CMS Warns States About Restricting Access to Hepatitis C Drugs
The federal government is concerned about low-income individuals having difficulty accessing high-priced hepatitis C drugs, according to the Associated Press. CMS reminded states that they cannot legally restrict access by low-income people, and also sent letters to drug manufacturers about what they are doing to make drugs more affordable.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen